Japan : Astellas, U.S. firm to develop, commercialize prostate cancer drug.Byline: pinto03 Japanese drugmaker Astellas Pharma Astellas Pharma Inc. (アステラス製薬株式会社 Inc and Medivation Inc, a U.S. biopharmaceutical firm, said Wednesday they have agreed to develop and commercialize worldwide a drug to treat prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. . According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the agreement, the two companies will work on a comprehensive development program, including further studies to develop Medivation s investigational drug MDV MDV mucosal disease virus. 3100 for various stages of prostate cancer, they said. While the two firms will jointly commercialize the drug in the United States, where they will equally share development and commercialization costs as well as profits, Astellas will be in charge of such activities outside the United States and pay Medivation royalties on sales, they added. Copyright : Euclid Infotech Pvt. Ltd. Provided by Syndigate.info an Albawaba.com company |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion